Member Info for GlenFidrich

OK, Wolfie, don't get out your pram.

In fairness, Wolfie, two wrongs don't make a right, plus the two examples you cite - Apple (a $2.85 trillion company!) and Ceres (a GBP1.21 billion company) - are hardly comparable to Sareum (current market cap. GBP124m and falling fast). I'm voting for consolidation, but I don't dismiss out of hand the views of those shareholders who will vote against. I think they probably feel hoodwinked by PH's appointment (which has done sweet foxtrot alpha for the SP) and see consolidation as a further attempt by PH to squeeze more money out of the company, and thereby shaft the innocent PIs. To ask how much this is all costing us I don't think is unreasonable. It may be "buttons" to you, or Apple Inc. for that matter (lol), but to Sareum PIs, who have seen the SP fall by 60% in 6 months, it's of interest.

"Stephen, Michael and Clive provide the Company with a wealth of industry and corporate finance experience." Wow, OK! Didn't they see PH coming in that case?

MrIndia, I view the arrival of these types of posts/posters as a positive. Paid derampers are commonplace on AIM, often appearing just before positive news is released in order to fleece the weak hands, spreading their fear and uncertainty so that their paymasters can hoover up shares on the cheap. Seen it many times over on SAR. I just think we need to sit on our hands and wait for news (which I'm fairly certain is imminent). AIMHO.

So, just for the record, I have huge respect for both TM and JR, as scientists. I actually think JR might be a better spokesperson, particularly when discussing the science and IP protection (he seems to drive the various patent applications). At the Edison Open House event, it was clear that Tim was reading from pre-prepared notes, and quite probably had been given the questions to answer in advance. I found this a bit feeble for someone so important within the company. One would have thought he had all the information in his immense brain and not needed to resort to notes. But hey, what do I know? But, no, Azz, I certainly want TM and JR to continue what they're doing, but perhaps give the public performances to someone less gauche and awkward. Just thinking aloud...

Just thinking out loud here, fellow Sareumites, so forgive me if my thoughts are a little jumbled. But:
1) On 6th August, 2021, we closed at 9.75p. Hurrah! Since then the SP has declined 6.1p, or 62% (coincidentally, almost the exact level associated with a fibonacci retracement - 61.8%). Are we, therefore, in oversold territory? Can we expect a fairly sizable rebound? I obviously hope so!
2) On 29th October, 2021, Peel Hunt were engaged as Joint Corporate Broker (no reason given, and somewhat strange given that we already had Hybridan in said role). The SP at the time stood at 6.65p. Since their appointment, the SP has declined 3p, or 45%. This, I'm afraid, does beg the question: What on earth have PH brought to the table, apart from a wealth of pain for shareholders? But it is what it is, I guess.
3) On 23rd November, 2021, Stephen Parker bought shares (a paltry, but welcome, 277,777 shares at 3.6p) and the SP spiked (as did the volume - interestingly, for the 2 trading days prior to the announcement and for the 3 days subsequently), finally peaking at 6.15p on December 1st. Since then, the SP has given up all those gains (a decline of 40%) on very thin volume (most days on volume of less than 10m shares). This absolutely reeks of manipulation.
4) Finally, on 16th December, 2021, we had the AGM statement, in which was announced the board's intention to consolidate the number of shares in issue. No details, no date were given, heralding another SP slide from 5.2p to current levels (a decline of 1.55p, or 30%). Coupled with the recent 'warrants debacle' (see both of the 28th January, 2022, RNSs) I'm left wondering if my investment is in safe hands? Like many here have said, the science appears cutting-edge but do we need a more inspiring mouthpiece to 'clinch the deal'? TM's performance at the recent Edison Open House event was cringe-worthy in the extreme.
My conclusion is that I've been here so long I might as well hang in there for now, see what transpires post-consolidation, but I can't help being a little baffled by all the SP erosion, and the apparent lack of direction or pertinent news.

MrIndia, you'll be welcome at my party should we hit 20p let alone a pound. GLA.

...traded, and we're down 4.5%? Really? I think the MMs need to grow up, if they think they can spook me into selling. This is becoming an increasingly common occurrence. A sure sign news is imminent.

...our golden tickets just got a lot more scarce, and 50x more expensive.
I, too, am wary of PH (particularly the German arm of the company - 'Peel ****z'), but what to do?
I mentioned a while ago OXB did something similar a few years back. Their SP doubled over the next few years so it's not all doom and gloom.
I just can't understand what the delay is regarding the toxicology report. It feels like our patience is being sorely tested, mostly since PH were engaged. Anyway, I'm holding for dear life but doubts are creeping in... Probably best to switch off until we get concrete news on the science.

Agree, Wolfie. Number of shares in issue post-consolidation = 68,069,416,

I'm sorry, but the 1st of February marked the 8-month anniversary of the following RNS:
https://www.lse.co.uk/rns/SAR/covid-19-research-project-results-j5q89njlqb68nqx.html
Edited highlights include:
1) "The results of the project found that SDC-1801 reduced the levels of cytokines associated with Acute Respiratory Distress Syndrome (ARDS) in human lung cells infected with SARS-CoV-2 and demonstrated a profile that was superior to the anti-inflammatory steroid dexamethasone and similar to baricitinib, a JAK1/JAK2 inhibitor." Great! So why, 8 months later, are we still awaiting a further update? This pandemic has been possibly the worst health crisis to hit the world in a century and seemingly a potential solution is going begging. Not good enough.
2) "The results from our Covid-19 research project are very encouraging and provide clear evidence of the potential of SDC-1801 to reduce the excessive inflammatory response seen in severe Covid-19." Encouraging for whom, pray? The people who are dying from Covid-19, still? The families who have since lost loved ones? The millions of people who have had their lives turned upside down? Again, I say, not good enough.
3) "The Grant for the project was awarded to Sareum through the Innovate UK Sustainable Innovation Fund for projects that address and mitigate the health, social, cultural and environmental impacts of the Covid-19 outbreak." Great! But if we're not going to follow through on the "encouraging results", why on earth did we apply for the grant in the first place? Once again, not good enough, and in addition a waste of taxpayers' money.
Sorry for the rant, but it's becoming increasingly clear that either someone is asleep at the wheel, or the apparently encouraging results are not what they initially seemed. Either scenario is, for me at least, a major concern.

Welcome to the world of biotech investments.

https://fortune.com/2022/02/02/biden-cancer-moonshot-research-treatment-flaws/

As an aside, the UT at close of play obviously skewed the real SP. We should open at 4p tomorrow, up 5% or so. (Just in case anyone is worried about the apparent 6.42% slide.)

Spank, if you are indeed incontinent and residing in a nursing home by the time SAR comes good, you'll probably also have forgotten you had any shares at all, let alone what the password is to your trading account, so it won't matter much either way! Let's hope SAR hits the jackpot before we're all too old (or too dead) to enjoy the fruits of our investment. GLA!

MrIndia, lol! I'm sorry, but I couldn't resist it! Long may the rise continue. Here's hoping...

Might silence MrDoomandGloom for a while, at least!

Matty, at one point I was 70% down on my investment in SAR. Almost 2 years later, I'm up 350%. Hopefully you'll recover any paper loss and also be in profit eventually. Just hang in there (if my experience is anything to go by).

https://www.nuventra.com/resources/blog/fda-pre-ind-meeting-guide/
Apologies if posted before, but perhaps a timely reminder of the whys and wherefores of the pre-IND meeting. Hemo requested this on December 13th I believe, and as the article states the meeting is normally scheduled for 60 days later i.e. around 13th February. Hopefully any feedback from the FDA would be shared by Hemo with all stakeholders, and thus some news might be expected sooner than the summer, surely?

So, roughly 29m shares traded (around 1% of shares in issue) and we're down 14%? How can this not be anything other than a massive over-reaction? Or am I missing something?

Beginning to feel like DMTR.